Prostate cancer is cancer that occurs in the prostate. Prostate cancer is the most frequently diagnosed male cancer and the fifth leading cancer-related mortality rate in men around the world. In 2020, there were 1,414,249 newly diagnosed cases and 375,000 fatalities worldwide due to this illness. The majority of prostate tumors grow slowly, are low-grade, have a modest risk, and are not particularly aggressive.
Age - Men under the age of 40 are less likely to develop prostate cancer than older men, although the risk increases significantly after age 50. Men older than 65 are infected by prostate cancer in about 6 out of 10 cases
Race/ethnicity - A man's risk of having prostate cancer is more than doubled if his father or sibling has the condition
Gene changes - Inherited mutations in the BRCA1 or BRCA2 genes linked to an elevated risk of breast and ovarian cancer can also raise the risk of prostate cancer in men (especially mutations in BRCA2)
Prostate cancer risk is higher in men who have Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), a disorder caused by inherited gene alterations
Screening for prostate cancer - Prostate screening tests include:
1. Prostatectomy – includes the removal of affected tissues and lymph nodes of the prostate gland. This can be done by 2 techniques:
2. Radiation therapy includes -
3. Freezing or heating prostate tissue -
4. Chemotherapy
5. Immunotherapy
6. Targeted drug therapy
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Millions of men could benefit from faster scan to diagnose prostate cancer
2.
Older Adults With Advanced Cancer Prioritize Quality of Life
3.
Intractable cancers may respond better to treatment when using new radiation and high-performance computing.
4.
Patients with head and neck cancer who cannot receive cisplatin now have new hope.
5.
Breast cancer screening in women's 40s can save lives, study says
1.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
2.
Cancer Vaccines in Solid Tumors: Current Landscape, Mechanisms, and Clinical Implications
3.
CEUS in Endometrial Cancer: A Tool for Early Myometrial Infiltration Detection
4.
Unraveling the Mysteries of Metastasis: Exploring the Latest Advances in Cancer Research
5.
Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
2.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
4.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
5.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation